Fibroblast Activation Protein Inhibitor Theranostics: A Huge Opportunity with its Fair Share of Oncological Pitfalls
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Fibroblast Activation Protein Inhibitor Theranostics: A Huge Opportunity with its Fair Share of Oncological Pitfalls ; volume:23 ; number:02 ; year:2024 ; pages:071-072
World Journal of Nuclear Medicine ; 23, Heft 02 (2024), 071-072
- Contributor
-
Al-Ibraheem, Akram
- DOI
-
10.1055/s-0044-1787886
- URN
-
urn:nbn:de:101:1-2408081158599.739288646278
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Al-Ibraheem, Akram
Other Objects (12)
FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
FDG-PET/CT pitfalls in oncological head and neck imaging
Mitochondria-targeting theranostics
Theranostics in prostaatkanker
Application of PSMA-ligands in the uro-oncological theranostics framework : Novel methods to image and treat prostate cancer
Polyrotaxane-based supramolecular theranostics
New trends in theranostics
Theranostics in prostate cancer
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
Highly Selective Inhibitors of Fibroblast-Activation-Protein for Imaging and Therapy of Oncological Diseases
CXCR4-targeted theranostics in oncology
Chemodynamic nanomaterials for cancer theranostics
FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
FDG-PET/CT pitfalls in oncological head and neck imaging
Mitochondria-targeting theranostics
Theranostics in prostaatkanker
Application of PSMA-ligands in the uro-oncological theranostics framework : Novel methods to image and treat prostate cancer
Polyrotaxane-based supramolecular theranostics
New trends in theranostics
Theranostics in prostate cancer
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
Highly Selective Inhibitors of Fibroblast-Activation-Protein for Imaging and Therapy of Oncological Diseases
CXCR4-targeted theranostics in oncology
Chemodynamic nanomaterials for cancer theranostics
FDG-PET/CT pitfalls in gynecological and genitourinary oncological imaging
FDG-PET/CT pitfalls in oncological head and neck imaging
Mitochondria-targeting theranostics
Theranostics in prostaatkanker
Application of PSMA-ligands in the uro-oncological theranostics framework : Novel methods to image and treat prostate cancer
Polyrotaxane-based supramolecular theranostics
New trends in theranostics
Theranostics in prostate cancer
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
Highly Selective Inhibitors of Fibroblast-Activation-Protein for Imaging and Therapy of Oncological Diseases
CXCR4-targeted theranostics in oncology